Article Text
Statistics from Altmetric.com
You do not have access to the full text of this article, the first page of the PDF of this article appears above.
Footnotes
Twitter @jonhagedornmd
Contributors All authors contributed to manuscript design and preparation. All authors agreed on the final draft.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests TD is a consultant for Abbott, Vertos, Axonics, Flowonix, Saluda Medical, Vertos, SpineThera, Nalu, Cornerloc, SPR Therapeutics and Vertiflex. TD is a member of the advisory board for Abbott, Flowonix, Nalu, SPR Therapeutics and Vertiflex. TD has equity options in Bioness, Vertiflex, Axonics, Vertos, SpineThera, Saluda Medical, Nalu and Cornerloc. He is a research consultant for Abbott, Mainstay Medical, Saluda, SPR Therapeutics and Vertiflex. TD has a patent pending for the DRG paddle lead with Abbott. DS is a consultant for Abbott, Flowonix, Nevro, SPR, Stimgenics, Vertiflex and Vertos. TL is a member of the advisory board for Vertos.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.